These results indicate that CD93, fibronectin, and MMRN2 are coexpressed in tumor vessels in glioma, and that the levels of these proteins are increased in higher malignancy grades, suggesting a functional role of the CD93-MMRN2-fibronectin complex during tumor angiogenesis. This evidence concerns the gene CD93 and glioma.